Tag:

Thoratec Corporation

Latest Headlines

Thoratec calls off $110M sale of ITC division

July 27, 2010

Thoratec Corporation, a maker of device-based mechanical circulatory support therapies, announced that it has canceled the previously-announced $110 million deal to sell its International Technidyne

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe

MORE EVENTS

Press Releases

Featured Jobs

Sr. IT Infrastructure Architect Job
Celgene Corporation - Berkeley Heights, NJ, US
Director, Shared Services Americas Lead Job
Celgene Corporation - Berkeley Heights, NJ, US
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US
Sr. Director, Healthcare Compliance Audit Job
Celgene Corporation - Summit, NJ, US

Thoratec Corporation

Latest Headlines

Latest Headlines

Thoratec calls off $110M sale of ITC division

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Thoratec Corporation

Latest Headlines

Latest Headlines

Thoratec calls off $110M sale of ITC division

Related Tags